1. Home
  2. |Insights
  3. |Federal Circuit Finds Computer-Readable Recording Medium Storing Instructions Patent-Eligible

Federal Circuit Finds Computer-Readable Recording Medium Storing Instructions Patent-Eligible

What You Need to Know

  • Key takeaway #1

    Whether a “computer-readable medium” includes transitory media depends primarily on the intrinsic evidence provided by a patent

  • Key takeaway #2

    Extrinsic evidence that contradicts intrinsic evidence should not be relied on

Client Alert | 2 min read | 05.02.23

In the April 12, 2023 decision in Sequoia Technology, LLC v. Dell, Inc., No. 21-2263, a case involving infringement and validity of a patent related to digital storage of data in a server, the Federal Circuit reversed the district court, in part, and held that a “computer-readable recording medium storing instructions” does not encompass transitory media. 

The district court consolidated a group of cases and referred the claim construction disputes to a magistrate judge who adopted a claim construction in which “computer-readable medium” (CRM) included transitory media (i.e., signals or waves), which are patent-ineligible.  The magistrate judge’s claim construction was based, at least in part, on extrinsic evidence provided by an expert witness that related to 34 different patents and patent applications with different express definitions of CRM that included transitory media.  The district court relied on, not only the magistrate judge’s Report and Recommendation, but also the lack of a clear statement in the specification of the patent that the CRM excluded transitory media. 

Based on the intrinsic evidence in the case, the Federal Circuit disagreed with the district court.  The Court noted that instead of reciting “computer-readable medium,” the claim of the patent recited the narrower limitation “computer-readable recording medium storing instructions.”  The court agreed that one of ordinary skill in the art would not understand transitory signals to record or store instructions in memory systems.  Further, the Court recognized that the claim recited “creating the logical volume … in a physical storage space” and “storing [sic] metadata to the disk partitions,” which demonstrate that the claim is directed to a non-transient storage medium. 

In addition to the claim itself, the Court found more intrinsic evidence supporting its claim construction in the specification, which discloses only non-transitory media in its list of examples of CRM (i.e., CDROM, RAM, and various types of disks).  Although the specification used the term “including,” which is generally considered to be an open-ended term, where it recites “a computer readable medium including … (CDROM), … (RAM), … and magneto-optical disk,” the Court concluded that the context of the entire patent makes clear that the term “computer-readable medium” cannot encompass transitory media.  The Court further stated that the term “non-transitory” need not be explicitly used in the claims or specification, where the intrinsic record demonstrates that the CRM does not reasonably include transitory media. 

The Federal Circuit decided that the district court erred in relying on the expert testimony, because it was inconsistent with the intrinsic evidence and because it was based on different express definitions of CRM in patent specifications directed to different inventions.  In its discounting of the expert testimony, the Court stated “extrinsic evidence of what other inventors chose to do cannot surmount the intrinsic evidence of what the inventors chose here; context is the key in claim construction.” 

This decision makes clear that “computer-readable recording medium storing instructions” is generally considered to be a patent-eligible way to recite a CRM.  Moreover, the decision provides a valuable reminder concerning the value of intrinsic evidence in a patent. 

Insights

Client Alert | 20 min read | 05.01.24

Key Developments in Artificial Intelligence (AI) and Digital Health Signal Growing Federal Activity (Q1 2024)

Digital health companies, investors, and other healthcare organizations should follow policy developments with a strategic lens towards their market opportunities for key potential growth and risk mitigation....